Maxcyte (MXCT) Assets Average (2021 - 2026)

Maxcyte (MXCT) has 6 years of Assets Average data on file, last reported at $198.5 million in Q1 2026.

• Assets Average for Q1 2026 came in at $198.5 million, down 15.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $198.5 million (down 15.43% YoY), and the FY2025 annual result was $221.0 million, down 12.95% from the prior year.
• Assets Average eased to $198.5 million in Q1 2026 per MXCT's latest filing, from $208.0 million in the prior quarter.
• Over five years, Assets Average peaked at $290.4 million in Q2 2022 and troughed at $198.5 million in Q1 2026.
• A 5-year average of $255.5 million and a median of $263.1 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2026: Assets Average surged 55.38% in 2022, then fell 15.43% in 2026.
• A 5-year view of Assets Average shows it stood at $286.5 million in 2022, then dropped by 6.64% to $267.5 million in 2023, then dropped by 8.77% to $244.0 million in 2024, then retreated by 14.77% to $208.0 million in 2025, then slipped by 4.57% to $198.5 million in 2026.
• Business Quant data shows MXCT's Assets Average at $198.5 million in Q1 2026, $208.0 million in Q4 2025, and $216.6 million in Q3 2025.